United States · 
What does Adjuvant Capital invest in?
Adjuvant Capital invests most often at Series A and Series D (100% of the rounds on record), in sectors such as Med Device, Medtech and Ivd.
Adjuvant Capital highlights
- 01
4 rounds on record
- 02
Mostly Series A and Series D: 100% of its rounds
- 03
Sole investor in 1 rounds, median $7.0M
What they do
Adjuvant is a new type of venture capital firm.From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- $100K – $300M as they say
- Stages
- SeedSeries ASeries BGrowth
- Sectors
- Med DeviceMedtechIvd
- Based in
- New York Mills, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first4 appearances
- 2019
4 rounds
- Nov
- Sept
- Sept
- Jul
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration4 named
EBEvelyn Beth YanatosDirector of Finance and Compliance; Chief Compliance OfficeriForm ADV
GAGlenn Anthony RockmanExecutive OfficeriFiling they signed
JYJenny YipExecutive OfficeriFiling they signed
KAKabeer AzizPartneriForm ADV
We also hold 19 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$170Mgross assets of its fundsOct 2026
Exemptreporting adviserventure or small private funds
- Legal name
- Adjuvant Capital, LP
- SEC number
- CRD 301716
What they claim to have backed
From their own portfolio page (on their website)
9 of 17 we have independently watched raise
54geneAn2therapeuticsAntivabioChromacodeEvofemFrontiernutritionIndevrMemo-therapeuticsPulmocideCurevovaccineLakeshorebioLmtbioMangrove-webQuantoomThemisbioVitrivaxbioexcision.bio
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.